Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Corticosteroid
|
| gptkbp:approvedBy |
1961
|
| gptkbp:ATCCode |
D07AC01
|
| gptkbp:brand |
gptkb:Betnovate
Alphatrex Celestone Diprolene Luxiq |
| gptkbp:CASNumber |
378-44-9
|
| gptkbp:contraindication |
hypersensitivity
systemic fungal infections |
| gptkbp:discoveredBy |
GlaxoSmithKline
|
| gptkbp:eliminationHalfLife |
36-54 hours
|
| gptkbp:excretion |
urine
|
| gptkbp:hasMolecularFormula |
C22H29FO5
|
| https://www.w3.org/2000/01/rdf-schema#label |
betamethasone
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:MeSH_ID |
D001668
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (oral, injectable)
C (topical) |
| gptkbp:PubChem_CID |
gptkb:CHEMBL413
9406 9782 DB00443 |
| gptkbp:relatedTo |
gptkb:dexamethasone
gptkb:prednisolone hydrocortisone |
| gptkbp:routeOfAdministration |
injection
oral topical intramuscular |
| gptkbp:sideEffect |
gptkb:bone
gptkb:Cushing's_syndrome immunosuppression hypertension weight gain hyperglycemia adrenal suppression skin thinning |
| gptkbp:UNII |
9842X06Q6M
|
| gptkbp:usedFor |
asthma
skin diseases autoimmune diseases adrenal insufficiency allergic disorders inflammatory conditions rheumatic disorders preterm labor (to promote fetal lung maturity) |
| gptkbp:bfsParent |
gptkb:Corticosteroid
gptkb:H02AB02 |
| gptkbp:bfsLayer |
6
|